Mark Kubik, MD
Title: “Update on HPV Related Oropharyngeal Cancer – Implications for Public Health / Vaccination Programs”
Mark Kubik’s primary clinical and research focus is on head and neck surgical oncology and reconstructive surgery.
His research interests include human papilloma virus (HPV) related oropharyngeal cancer, optimizing functional outcomes following microvascular reconstruction, and robotic surgery.Dr. Kubik’s primary clinical interests include oncologic surgery for tumors of the head and neck region, including skull base, thyroid, and salivary gland. He has a specific clinical expertise in microvascular reconstruction following trauma or cancer surgery. His goals for patient care include a comprehensive and multidisciplinary approach to each patient to provide the best cure, quality of life, and cosmesis.Dr. Kubik, graduated from the University of Notre Dame in 2009 and then received his medical degree from Baylor College of Medicine. He completed his residency in Otolaryngology at the University of Pittsburgh before pursuing a fellowship in Head and Neck Oncologic and Microvascular Surgery at the Medical University of South Carolina. Following fellowship, he joined the faculty as an assistant professor at the University of Pittsburgh Medical Center with joint appointments in Otolaryngology and Plastic Surgery.
Originally published at harpercancer.nd.edu.